387 related articles for article (PubMed ID: 26973812)
1. Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.
Challapalli A; Aboagye EO
Front Oncol; 2016; 6():44. PubMed ID: 26973812
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysis.
Kwee SA; Lim J
World J Radiol; 2016 Nov; 8(11):851-856. PubMed ID: 27928466
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated tracers for imaging cancer with positron emission tomography.
Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.
Salem N; Kuang Y; Wang F; Maclennan GT; Lee Z
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):144-56. PubMed ID: 19039303
[TBL] [Abstract][Full Text] [Related]
6. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
9. The role of (
Pan L; Zhang F; Ran Y; Bi L; Jin H; Yao L
Diagn Interv Radiol; 2023 May; 29(3):548-554. PubMed ID: 37154799
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging of prostate cancer.
Hong H; Zhang Y; Sun J; Cai W
Amino Acids; 2010 Jun; 39(1):11-27. PubMed ID: 19946787
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.
Witney TH; Alam IS; Turton DR; Smith G; Carroll L; Brickute D; Twyman FJ; Nguyen QD; Tomasi G; Awais RO; Aboagye EO
Clin Cancer Res; 2012 Feb; 18(4):1063-72. PubMed ID: 22235095
[TBL] [Abstract][Full Text] [Related]
12. PET Tracers Beyond FDG in Prostate Cancer.
Schuster DM; Nanni C; Fanti S
Semin Nucl Med; 2016 Nov; 46(6):507-521. PubMed ID: 27825431
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Preliminary Evaluation of an
Murakami Y; Fujita Y; Fushiki H
Mol Imaging Biol; 2023 Jun; 25(3):495-502. PubMed ID: 36220956
[TBL] [Abstract][Full Text] [Related]
14. Dual-tracer positron emission tomography/computed tomography as an imaging probe of
Tsao CH; Jhou RH; Ke CC; Chang CW; Chang CW; Yang BH; Huang WS; Shih BF; Liu RS
Front Med (Lausanne); 2022; 9():1008200. PubMed ID: 36237546
[TBL] [Abstract][Full Text] [Related]
15. Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.
Sankaranarayanapillai M; Zhang N; Baggerly KA; Gelovani JG
Mol Imaging Biol; 2013 Apr; 15(2):136-47. PubMed ID: 22886728
[TBL] [Abstract][Full Text] [Related]
16. Metabolic positron emission tomography imaging in cancer detection and therapy response.
Zhu A; Lee D; Shim H
Semin Oncol; 2011 Feb; 38(1):55-69. PubMed ID: 21362516
[TBL] [Abstract][Full Text] [Related]
17. Non FDG PET.
Nanni C; Fantini L; Nicolini S; Fanti S
Clin Radiol; 2010 Jul; 65(7):536-48. PubMed ID: 20541653
[TBL] [Abstract][Full Text] [Related]
18. Dynamic 2-Deoxy-2-[
Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
